The benefits of mammographic screening for breast cancer are not clear for women less than 50 years old.
Our aim was to evaluate the effectiveness of breast cancer screening in different age groups.
A mammographic breast cancer-screening program with a 2-year screening interval has been under way in Nijmegen, The Netherlands, since 1975.
After eight rounds, more than 40 000 women have been invited to participate.
All breast cancer cases diagnosed in the invited population, whether detected by screening or clinically, have been considered in this study.
The age groups are younger than 50 years, 50-69 years, and 70 years or older at last invitation before diagnosis.
Mots-clés Pascal : Tumeur maligne, Glande mammaire, Programme sanitaire, Dépistage, Pays Bas, Europe, Age, Homme, Glande mammaire pathologie
Mots-clés Pascal anglais : Malignant tumor, Mammary gland, Sanitary program, Medical screening, Netherlands, Europe, Age, Human, Mammary gland diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0447104
Code Inist : 002B20E02. Création : 199406.